Mechler C, Bounacer A, Suarez H, Saint Frison M, Magois C, Aillet G, Gaulier A
Department of Pathology, C.H. Victor Dupouy, 95107 Argenteuil cedex, France.
Br J Cancer. 2001 Dec 14;85(12):1831-7. doi: 10.1054/bjoc.2001.2187.
Familial papillary thyroid carcinoma (PTC) is a well recognized disease. However, genetic predisposition to familial PTC is rare and the molecular alterations at the origin of the pathology are unknown. The association between PTC and lymphocytic thyroiditis (LT) has been reported recently. We communicate here 6 cases of PTC associated with LT in 2 unrelated families. PTC was diagnosed on classical nuclear and architectural criteria. It was bilateral in 5 cases. Architecture was equally distributed between typical PTC and its follicular variant. LT was present in variable degrees, including in 4 cases, oncocytic metaplasia. Using the RT-PCR technique, we observed a RET/PTC rearrangement in the carcinomatous areas of patients of both families: PTC1 in family 1 and PTC3 in family 2 and a RET/PTC rearrangement in non-malignant thyroid tissue with LT in family 2. The RET/PTC band was weaker or absent in pure LT areas. Furthermore, using a polyclonal ret antibody, an apical or a diffuse cytoplasmic ret onc protein immunolabelling was observed in the three patients with RET/PTC1 rearrangement and in the three patients with RET/PTC3 rearrangement. In conclusion our data: (1) show the presence of a RET/PTC 1 or 3 rearrangement (depending on the family) together with a variable expression of ret protein in all the PTCs; (2) suggest that the molecular event at the origin of the PTCs seems to be particular to each one of the studied families; and (3) confirm that the ret proto-oncogene activating rearrangement(s) is an early event in the thyroid tumorigenic process and that it can be observed in association with LT.
家族性乳头状甲状腺癌(PTC)是一种广为人知的疾病。然而,家族性PTC的遗传易感性罕见,其病理起源的分子改变尚不清楚。最近报道了PTC与淋巴细胞性甲状腺炎(LT)之间的关联。我们在此报告2个无亲缘关系家族中6例与LT相关的PTC病例。PTC根据经典的核和结构标准诊断。5例为双侧发病。结构在典型PTC及其滤泡变体之间均匀分布。LT程度各异,包括4例存在嗜酸性化生。使用逆转录聚合酶链反应(RT-PCR)技术,我们在两个家族患者的癌组织区域观察到RET/PTC重排:家族1为PTC1,家族2为PTC3,并且在家族2的伴有LT的非恶性甲状腺组织中也观察到RET/PTC重排。在纯LT区域,RET/PTC条带较弱或缺失。此外,使用多克隆ret抗体,在3例RET/PTC1重排患者和3例RET/PTC3重排患者中观察到顶端或弥漫性细胞质ret癌蛋白免疫标记。总之,我们的数据:(1)显示所有PTC中存在RET/PTC 1或3重排(取决于家族)以及ret蛋白的可变表达;(2)提示PTC起源的分子事件似乎在每个研究家族中都有其特殊性;(3)证实ret原癌基因激活重排是甲状腺肿瘤发生过程中的早期事件,并且可以与LT相关联观察到。